GEMAC - Clinical diagnostics

Research & development

Technical concept

Strategy development

Product : MSDiag®

References



> GEMAC home.
Clinical diagnostics - Research and development

Several years of research are based on the immunochemistry of small size molecules (< 1000 Daltons) including aminoacids, neurotransmitters, neuromodulators, sugar, vitamins, lipids, hormones, fatty acids...
In the meantime, a new concept appeared following relevant experimental observations: direct participation of small molecules in some pathogenic processes.

Focus: Identification of specific antibodies to small size molecules (new markers) circulating in patients affected by chronic degenerative or autoimmune diseases:

Multiple Sclerosis (MS)
Amyotrophic Lateral Sclerosis (ALS)
Rheumatoid arthritis (RA)
Parkinson disease
Alzheimer disease
Atypical neuropathies